针对C3球囊病的新型治疗策略:补充阻塞
Safak Mirioglu1,2, Savas Ozturk3
1Division of Nephrology, Department of Internal Medicine, Istanbul Faculty of Medicine, Istanbul University, 34093, Fatih, Istanbul, Turkey. smirioglu@gmail.com.
International urology and nephrology
|December 3, 2025
概括
C3球囊病 (C3G) 是一种罕见的病,治疗选择有限. 新型补充向药物,如伊普塔科潘和佩格塞塔科普兰,对控制C3G和预防功能衰竭有很大的前景.
科学领域:
- 腎臟病學 (nephrology) 是一種醫學專業.
- 免疫学 免疫学 免疫学
- 药理学 药理学是指药理学的学科.
背景情况:
- C3球囊病 (C3G) 是一种罕见的病,由补充替代途径失调驱动.
- 目前的治疗方法有效性有限,功能衰竭和移植后复发率高.
- 现有的治疗方法包括RAS抑制剂,类固醇,酸和eculizumab,反应可变.
研究的目的:
- 审查C3球囊病的新型治疗策略.
- 专注于新兴代理商,针对C3G管理中的补充系统.
- 提供C3G处理近期进展的概述.
主要方法:
- 对C3G.新型治疗策略的文献综述.
- 对针对补充系统的新兴药物的分析.
- 最近FDA对C3G疗法的批准的摘要.
主要成果:
- 传统的治疗有效性有限,移植后C3G复发率高.
- 埃奎利祖马布在侵袭性C3G中显示出有效性,但不是缓慢渐进的形式.
- 伊普塔科潘和佩格塞塔科普兰代表着有前途的新疗法选择,最近获得FDA批准.
结论:
- 新型补充向剂为C3G患者提供了改善的治疗前景.
- 伊普塔科潘和佩格塞塔科普兰是C3G治疗的关键进展.
- 需要进一步的研究才能充分确定新的C3G疗法的长期疗效和安全性.
相关概念视频
Open Angle Glaucoma: Treatment
934
In open-angle glaucoma, the iridocorneal angle remains open, but the trabecular meshwork becomes stiff, slowing down the outflow of aqueous humor. This causes a buildup of aqueous humor in the anterior chamber, leading to a sudden increase in intraocular pressure. The treatment for open-angle glaucoma focuses on reducing the elevated intraocular pressure by either decreasing the secretion of aqueous humor or increasing its outflow.
Drugs such as carbonic anhydrase inhibitors, α2- and...
Drugs such as carbonic anhydrase inhibitors, α2- and...
934
Angle Closure Glaucoma: Treatment
1.1K
Angle-closure glaucoma, or closed-angle glaucoma, is an eye condition where the iris bulges out and blocks the iridocorneal angle, resulting in a buildup of aqueous humor and increased intraocular pressure. Immediate medical attention is necessary due to the sudden onset of symptoms. The treatment for angle-closure glaucoma includes short-term and long-term approaches. Short-term treatment involves using eye drops like pilocarpine to lower intraocular pressure by increasing aqueous humor...
1.1K
Complement System
9.6K
The complement system is a group of approximately 20 plasma proteins that strengthen the body's defenses against infections through opsonization, inflammation, and cell lysis. Opsonization involves coating pathogens with complement proteins, making them more recognizable and facilitating phagocyte engulfment. Certain complement proteins induce inflammation that attracts immune cells to the site of infection. Cell lysis involves the destruction of pathogens through the formation of a...
9.6K
Chronic Kidney Disease III: Interprofessional Care
323
Chronic kidney disease (CKD) requires collaborative and comprehensive management. CKD progresses through stages and can lead to end-stage kidney disease (ESKD) if untreated. Interprofessional collaboration and patient education are crucial, enabling patients to manage their health and improve their quality of life.Diagnostic approach for chronic kidney diseaseThe diagnosis of CKD primarily focuses on the glomerular filtration rate (GFR), which assesses kidney function by measuring how well...
323
Nephrotic Syndrome III : Nursing Management
271
Nursing management for nephrotic syndrome adapts as the disease progresses, with strategies evolving to address advancing symptoms and complications.Early-Stage Management In the early stages, nursing interventions for nephrotic syndrome resemble those used in managing acute glomerulonephritis, focusing on symptom monitoring, fluid balance, and managing mild to moderate edema.Vital Signs: Regularly monitor blood pressure, pulse, respiratory rate, and temperature to promptly identify...
271
Nephrotic Syndrome II : Assessment and Medical Management
184
IntroductionNephrotic syndrome is a kidney disorder marked by excessive protein loss in the urine, leading to various systemic complications. This condition often results from damage to the glomeruli—the kidney's filtering units—causing proteinuria, low blood protein levels, and fluid retention. Understanding the assessment, diagnosis, and management of nephrotic syndrome is essential for effective treatment and prevention of further kidney damage.AssessmentPatient History: Document...
184


